A new global review reveals how rapidly evolving H5 bird flu viruses are reaching new species, including dairy cattle, and stresses the urgent need for coordinated action to prevent the next pandemic.
Since its discovery in 1996, the Gs/Gd lineage of highly pathogenic avian influenza viruses with H5 haemagglutinin, including H5N1 and other H5Nx subtypes, has caused widespread infections and mortality among numerous animal species and sporadic infections among humans, with outbreaks now reaching every continent, even Antarctica.
In a recent review published in the journal Nature Reviews Microbiology, researchers at the Department of Viroscience, Erasmus MC, the Netherlands, reviewed the current knowledge on the evolution, global spread, and growing risks posed by this persistent and adaptable virus.
Influenza viruses
Influenza A viruses have caused four human pandemics and countless outbreaks among animal populations in the past century. Among them, highly pathogenic avian influenza viruses (HPAIVs) pose a major threat due to their ability to evolve rapidly. While most avian influenza viruses circulate harmlessly among wild waterbirds, some have mutated into more deadly forms, particularly the H5 and H7 subtypes. When these viruses spill over to poultry, they can evolve into highly pathogenic forms that cause severe disease and death.
The Gs/Gd lineage of H5 viruses, which includes the well-known H5N1 subtype (first identified in humans in Hong Kong in 1997) and other H5Nx variants, emerged from a complex mix of avian viruses and has since diversified into numerous lineages. This lineage has become a dominant global threat, spreading across continents and infecting a wide range of birds and mammals. Furthermore, despite ongoing surveillance and control efforts, gaps remain in understanding how this virus spreads, evolves, and adapts to new hosts, including humans.
The current study
The researchers conducted a comprehensive review of scientific literature, surveillance reports, and genetic analyses to understand the evolution and spread of highly pathogenic H5 avian influenza viruses of the Gs/Gd lineage. They traced the virus’s origins back to a 1996 outbreak in domestic geese in Guangdong, China, and followed its genetic diversification through global outbreaks over the past 25 years.
The team examined how the virus has changed through a process known as reassortment, where gene segments from different influenza viruses mix in co-infected hosts, creating new virus variants. They focused on outbreaks in wild birds, poultry, and mammals, including tigers, sea lions, mink, and dairy cattle.
The study also analyzed how the virus crosses species barriers. This included reviewing molecular data on mutations in viral proteins, including hemagglutinin, neuraminidase, and polymerase components, that help the virus adapt to mammalian cells. Structural features of hemagglutinin that affect binding to host receptors, as well as changes in viral ribonucleic acid (RNA) polymerase that enhance replication in mammals, were examined. Additionally, the study investigated the immune responses in different species and how the virus evades these defenses.
To assess the impact on human health, the authors also reviewed data on confirmed human infections, exposure risks, and clinical symptoms, considered the role of environmental and agricultural practices in facilitating the spread of the virus, and examined current control measures like culling, vaccination, and surveillance.
Key findings
The study reported that the H5 viruses from the Gs/Gd lineage have undergone significant genetic evolution, enabling them to infect a wider range of species and persist globally. The virus, which originally circulated in poultry, has now spread to wild birds and mammals, including rare spillovers into humans.
Most alarmingly, it has recently reached dairy cattle in the United States, where it has spread primarily due to the movement of infected animals between farms. Contaminated milking equipment facilitates transmission within farms and causes widespread infections. The virus has now been detected on every continent, including Antarctica, marking an unprecedented expansion.
Its ability to reassort with other influenza viruses has also generated multiple variants, including those with new gene combinations that enhance adaptation to mammals. This genetic mixing has also improved the virus’s ability to bind to human-like receptors and resist mammals’ innate immune defenses.
Since 1997, there have been over 1,000 laboratory-confirmed cases of Gs/Gd lineage infections in humans, with more than 500 reported deaths; however, the true case fatality rate is uncertain due to likely underreporting of mild and subclinical infections and variability in severity between outbreaks. Most infections occurred after direct contact with infected poultry, but recent cases in the U.S. involving dairy farm workers suggested new transmission routes. Though sustained human-to-human transmission has not occurred, the increase in mild or undetected human infections raises concerns about pandemic potential.
The virus has also had devastating impacts on wildlife, with high mortality among sea lions, seals, and birds being documented across the Americas and Europe. Mammal-to-mammal transmission, especially in farmed mink and sea lion colonies, also indicates that the virus may be evolving toward more efficient spread among mammals.
The review highlights that available options for managing outbreaks in wildlife are limited and may include carcass removal and targeted vaccination of endangered species.
Conclusions
The ongoing spread and evolution of the Gs/Gd H5 lineage viruses, including H5N1 and other H5Nx subtypes, emphasize the serious threat these influenza viruses pose to animals, ecosystems, and human health. With increasing evidence of cross-species transmission and global distribution, this virus remains a looming concern.
The review highlights the critical need for a unified “One Health” approach that integrates animal, human, and environmental health strategies at a global level. The review indicated that strengthening surveillance, advancing vaccine strategies, expanding the use of newer vaccine technologies, coordinating international vaccine stockpiling and deployment, and integrating efforts across animal and human health sectors are crucial steps towards preventing future outbreaks and reducing the risk of a potential pandemic.
- Bellido-Martín, B., Rijnink, W.F., Iervolino, M. et al. (2025). Evolution, spread and impact of highly pathogenic H5 avian influenza A viruses. Nature Reviews Microbiology, DOI: 10.1038/s41579-025-01189-4, https://www.nature.com/articles/s41579-025-01189-4

News
Specially engineered antibody delivers RNA therapy to treatment-resistant tumors
Elias Quijano, PhD; Diana Martinez-Saucedo, PhD; Zaira Ianniello, PhD; and Natasha Pinto-Medici, PhD, there are 25 other contributors, most from Yale's Department of Therapeutic Radiology and from the departments of genetics, molecular biophysics and [...]
Vaccinated women face fewer cervical cancer risks
New data from Denmark shows the HPV vaccine’s powerful long-term impact, while also revealing why cervical cancer screening is still essential. A Danish study published in the journal Eurosurveillance reports that women who received the human [...]
3D-printed implant offers a potential new route to repair spinal cord injuries
A research team at RCSI University of Medicine and Health Sciences has developed a 3-D printed implant to deliver electrical stimulation to injured areas of the spinal cord, offering a potential new route to [...]
Nanocrystals Carrying Radioisotopes Offer New Hope for Cancer Treatment
The Science Scientists have developed tiny nanocrystal particles made up of isotopes of the elements lanthanum, vanadium, and oxygen for use in treating cancer. These crystals are smaller than many microbes and can carry isotopes of [...]
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]